Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-)radiation

被引:0
|
作者
Bojaxhiu, Beat [1 ,2 ]
Templeton, Arnoud J. [3 ,4 ]
Elicin, Olgun [1 ,2 ]
Shelan, Mohamed [1 ,2 ]
Zaugg, Kathrin [6 ]
Walser, Marc [7 ]
Giger, Roland [5 ]
Aebersold, Daniel M. [1 ,2 ]
Dal Pra, Alan [1 ,2 ]
机构
[1] Bern Univ Hosp, Inselspital Bern, Dept Radiat Oncol, Bern, Switzerland
[2] Univ Bern, Bern, Switzerland
[3] St Claraspital Basel, Dept Med Oncol, Basel, Switzerland
[4] Univ Basel, Fac Med, Basel, Switzerland
[5] Univ Hosp, Inselspital Bern, Dept Otorhinolaryngol, Bern, Switzerland
[6] Stadtspital Triemli, Dept Radiat Oncol, Zurich, Switzerland
[7] Paul Scherrer Inst, Ctr Proton Therapy, Villigen, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:13S / 14S
页数:2
相关论文
共 50 条
  • [1] Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation
    Beat Bojaxhiu
    Arnoud J. Templeton
    Olgun Elicin
    Mohamed Shelan
    Kathrin Zaugg
    Marc Walser
    Roland Giger
    Daniel M. Aebersold
    Alan Dal Pra
    [J]. Radiation Oncology, 13
  • [2] Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation
    Bojaxhiu, Beat
    Templeton, Arnoud J.
    Elicin, Olgun
    Shelan, Mohamed
    Zaugg, Kathrin
    Walser, Marc
    Giger, Roland
    Aebersold, Daniel M.
    Dal Pra, Alan
    [J]. RADIATION ONCOLOGY, 2018, 13
  • [3] Neutrophil-to-lymphocyte ratio (NLR) and survival in recurrent or metastatic head and neck cancer patients treated with immunotherapy
    Franco, A.
    Tresch, E.
    Sakji, I.
    Makhloufi, S.
    Abdeddaim, C.
    Julieron, M.
    Dansin, E.
    Chevalier, D.
    Mouawad, F.
    Lefebvre, G.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S676 - S676
  • [4] Neutrophil-to-lymphocyte ratio in head and neck cancer
    Haddad, Carol R.
    Guo, Linxin
    Clarke, Stephen
    Guminski, Alex
    Back, Michael
    Eade, Thomas
    [J]. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2015, 59 (04) : 514 - 519
  • [5] The Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Head and Neck Cancer Patients Treated with Radiotherapy
    Cho, Yeona
    Kim, Jun Won
    Yoon, Hong In
    Lee, Chang Geol
    Keum, Ki Chang
    Lee, Ik Jae
    [J]. JOURNAL OF CLINICAL MEDICINE, 2018, 7 (12)
  • [6] Prognostic impact of the neutrophil-to-lymphocyte ratio (NLR) on overall survival in patients treated with chemoradiotherapy for head and neck cancer
    Makhloufi, S.
    Lefebvre, G.
    Sakji, I.
    Feutry, F.
    Leroy, T.
    Penel, N.
    Coche, B.
    Fourquet, J.
    Ghestem, F.
    Julieron, M.
    Chevalier, D.
    Tresch, E.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [7] Neutrophil-to-Lymphocyte Ratio Predicts Survival in Head and Neck SCC Treated with Definitive Chemoradiotherapy
    Chandrasekara, S.
    Davis, S.
    Thomson, P.
    Haydon, A.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 56 - 56
  • [8] Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with clinical outcome in recurrent or metastatic head and neck cancer patients treated with nivolumab
    Ueda, Tsutomu
    Chikuie, Nobuyuki
    Takumida, Masaya
    Furuie, Hiromi
    Kono, Takashi
    Taruya, Takayuki
    Hamamoto, Takao
    Hattori, Minoru
    Ishino, Takashi
    Takeno, Sachio
    [J]. ACTA OTO-LARYNGOLOGICA, 2020, 140 (02) : 181 - 187
  • [9] Prognostic value of neutrophil-to-lymphocyte ratio in older patients with head and neck cancer
    Ku, Ja Yoon
    Roh, Jong-Lyel
    Kim, Sung-Bae
    Choi, Seung-Ho
    Nam, Soon Yuhl
    Kim, Sang Yoon
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (03) : 417 - 422
  • [10] Prognosis and Neutrophil-to-Lymphocyte Ratio in Nivolumab-treated Patients with Recurrent/Metastatic Head and Neck Cancer
    Ota, I.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1174 - 1174